We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Merger Expected to Accelerate Development of Personalized Medicine Solutions

By HospiMedica International staff writers
Posted on 28 Dec 2014
Print article
Acquisition of an American company specializing in data management and analysis by a worldwide leader in genomics research and diagnostics development is expected to decrease the complexity, time, and cost of genomic analysis and accelerate development of the science of personalized medicine.

The biotech company Roche (Basel, Switzerland), an acknowledged leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics, has announced the acquisition of the American company Bina Technologies, Inc. (Redwood City, CA, USA).

Bina’s integrated, scalable, and comprehensive analysis platform, Genomic Management Solution or Bina-GMS1, empowers clinical and academic researchers to gain insight from their genomics data sets by dramatically decreasing the complexity, time, and cost of the analysis, accelerating the science of personalized medicine. The Bina Genome Analysis Platform includes a cancer pipeline that implements an integrative approach to identify and rank the most clinically important mutations based on a combination of different algorithms, sequencing features, and prior knowledge.

"The acquisition of Bina is a significant step for Roche to enable the promise of personalized healthcare by delivering the highest quality genomic data possible," said Dan Zabrowski, head of sequencing at Roche. "Informatics and data management are critical to providing a seamless, end-to-end sequencing solution. Bina's products are designed to improve the efficiency and value of genomic analysis, and the company continues to develop new methodologies and algorithms that link NGS data to disease-relevant genetic markers."

"Roche's acquisition of Bina is a great validation of our work and technology. It is also an indication of how informatics and data science are going to play a major role in the future of medicine," said Narges Bani Asadi, CEO of Bina. "We found great alignment between our company's vision and values, and we are very excited about the possibilities of working with Roche's global team and serving academic, translational, and clinical research markets together in the future."

It is expected that the acquisition by Roche will enable Bina to accelerate product development and global commercialization of Bina-GMS as an enterprise software system supporting multiple sequencing technologies while developing a solution for Roche sequencing systems.

Related Links:

Roche
Bina Technologies, Inc.


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Medical Gas Blender
BlenderBuddy 1

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.